Researchers from SWOG Cancer Research Network have significantly extended median survival for patients with hormone-sensitive metastatic prostate cancer. This result comes from a large randomized clinical trial aimed at testing a new treatment for th ...
Patients with metastatic hormone receptor-positive breast cancer who have low activity levels of the enzyme sTK1 in their blood serum at the start of anti-estrogen treatment live longer and go longer without their disease progressing than patients wi ...
Researchers with the SWOG Cancer Research Network have found that patients with metastatic hormone receptor-positive breast cancer who have low activity levels of the enzyme sTK1 in their blood serum at the start of anti-estrogen treatment live longe ...
Recent research in a SWOG Cancer Research Network trial that put three targeted drugs to the test, found cabozantinib, which is a small molecule inhibitor, most effective in treating patients with metastatic papillary kidney cancer. ...
In a SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer - findings expected to change medical p ...
A two and half hours a week of exercise can help women not only to live longer but are also more likely to remain cancer-free after their treatment, according to a recent study. ...
The results of a study on breast cancer patients show that women who exercise not only live longer, but also are more likely to remain cancer-free after their treatment. ...